HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME Test (opens in a new window) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nicolet, V. Articles by Prosmanne, O. Search for Related Content PubMed PubMed Citation Articles by Nicolet, V. Articles by Prosmanne, O. Related Collections Magnetic Resonance Imaging Obstetric/Gynecologic Radiology

MR Imaging of Cervical Carcinoma: A Practical Staging Approach¹

¹ From the Department of Radiology, CHUM, Hôpital Notre-Dame, 1560 Sherbrooke Est, Montréal, Québec, Canada H2L 4M1. Presented as a scientific exhibit at the 1999 RSNA scientific assembly. Received February 24, 2000; revision requested March 21 and received May 10; accepted May 11. Address correspondence to V.N. (e-mail: vnicolet@videotron.ca).

Cervical carcinoma is the third most common gynecologic malignancy and is typically seen in younger women, often with serious consequences. The International Federation of Gynecology and Obstetrics (FIGO) staging system provides worldwide epidemiologic and treatment response statistics. However, there are significant inaccuracies in the FIGO staging system, and magnetic resonance (MR) imaging, although not included in that system, is now widely accepted as optimal for evaluation of important prognostic factors such as lesion volume and metastatic lymph node involvement that will help determine the treatment strategy. MR imaging examination obviates the use of invasive procedures such as cystoscopy and proctoscopy, especially when there is no evidence of local extension. Brachytherapy and external beam therapy are optimized with MR imaging evaluation of the shape and direction of lesion growth. In general, T2-weighted MR imaging more clearly delineates cervical carcinoma and is preferred for evaluation of the lymph nodes. Dynamic gadolinium-enhanced T1-weighted imaging may help identify smaller tumors, detect or confirm invasion of adjacent organs, and identify fistulous tracts. MR imaging staging, when available, is invaluable for identifying important prognostic factors and optimizing treatment strategies.

Index Terms: Uterine neoplasms, 854.32 • Uterine neoplasms, MR, 854.12141, 854.121415, 854.12143 • Uterine neoplasms, staging, 854.12141

This article has been cited by other articles:

				E. Sala, S. Wakely, E. Senior, and D. Lomas MRI of Malignant Neoplasms of the Uterine Corpus and Cervix Am. J. Roentgenol., June 1, 2007; 188(6): 1577 - 1587. [Abstract] [Full Text] [PDF]

				W. Park, Y. J. Park, S. J. Huh, B. G. Kim, D. S. Bae, J. Lee, B. H. Kim, J. Y. Choi, Y. C. Ahn, and D. H. Lim The Usefulness of MRI and PET Imaging for the Detection of Parametrial Involvement and Lymph Node Metastasis in Patients with Cervical Cancer Jpn. J. Clin. Oncol., May 1, 2005; 35(5): 260 - 264. [Abstract] [Full Text] [PDF]